Citation Impact
Citing Papers
Deciphering O -glycoprotease substrate preferences with O-Pair Search
2022 StandoutNobel
The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus
2009
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases
2024 StandoutNobel
Systematic and Quantitative Assessment of Hydrogen Peroxide Reactivity With Cysteines Across Human Proteomes
2017
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Lineage-Specific Changes in Biomarkers in Great Apes and Humans
2015 StandoutNobel
The Role of Macrophages in Acute and Chronic Wound Healing and Interventions to Promote Pro-wound Healing Phenotypes
2018 Standout
Anti-inflammatory activity of natural dietary flavonoids
2010 Standout
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
2018
The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
2019
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
2013
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
O-Pair Search with MetaMorpheus for O-glycopeptide characterization
2020 StandoutNobel
Chemokines in Renal Injury
2011
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Emerging concepts of type I interferons in SLE pathogenesis and therapy
2022
Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus
2010
Revealing the human mucinome
2022 StandoutNobel
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
2013 Standout
Glycosylation in health and disease
2019
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
Phenotype, function, and differentiation potential of human monocyte subsets
2017
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>
2020 Standout
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
2018
Basic and Clinical Immunology of Siglecs
2008
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
2010 StandoutNobel
High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block
2017
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Tissue-resident dendritic cells and diseases involving dendritic cell malfunction
2016
The Changing Landscape of Renal Inflammation
2016
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
2019
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
2022 StandoutNobel
Glycoproteomics
2022 StandoutNobel
Deacetylated sialic acids modulates immune mediated cytotoxicity via the sialic acid-Siglec pathway
2021 StandoutNobel
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Uniquely human evolution of sialic acid genetics and biology
2010
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity
2021 StandoutNobel
Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus
2020
CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
2013
Genetics and genomics of ankylosing spondylitis
2009
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon
2019
ICOS Controls Effector Function but Not Trafficking Receptor Expression of Kidney-Infiltrating Effector T Cells in Murine Lupus
2009
Siglec‐1 and ‐2 as potential biomarkers in autoimmune disease
2016
Works of Robert Biesen being referenced
Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis
2018
CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients
2008
Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?
2013
Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function
2009
Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: A semi-mature and myeloid-like subset imbalanced during protective and autoimmune responses
2015
From transcriptome to cytome: Integrating cytometric profiling, multivariate cluster, and prediction analyses for a phenotypical classification of inflammatory diseases
2008
IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus
2012
Sialic acid–binding Ig‐like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus
2008
SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome
2016
The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity
2014